首页 > 最新文献

Revista da Associacao Medica Brasileira最新文献

英文 中文
Comparison of pain levels developed during intramuscular injections to laterofemoral and ventrogluteal regions in children: a randomized controlled study. 一项随机对照研究:儿童股骨外侧和腹肌区域肌肉注射期间疼痛水平的比较。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20220770
Serap Balci, Birsen Bilgen Sivri

Objective: The aim of this study was to compare the levels of pain developed during intramuscular injections to the laterofemoral and ventrogluteal regions in children.

Methods: The study population consisted of all children aged between 7 and 12 years who presented to the pediatric emergency clinic of a hospital. The sample consisted of 62 children who met the inclusion criteria and agreed to participate in the study, and the children were randomly assigned to each group (laterofemoral n=31, ventrogluteal n=31). "Buzzy" and "deep breathing" were applied to children in both groups to relieve pain during the procedure. The data were obtained using an Information Form, a visual analog scale, and the Facial Pain Scale-Revised.

Results: It was determined that the children in the ventrogluteal group during the intramuscular injections had lower visual analog scale and faces pain scale-revised scores immediately after the procedure compared with the vastus lateralis group, that is, they experienced less pain, and the difference between the two groups was significant (p<0.001).

Conclusion: In children, it is recommended to choose the less painful ventrogluteal region for intramuscular injection and to inform health professionals about it.

目的:本研究的目的是比较儿童在股外侧和腹肌区域肌肉注射时产生的疼痛水平。方法:研究人群包括所有在某医院儿科急诊就诊的7 - 12岁儿童。样本包括62名符合纳入标准并同意参与研究的儿童,这些儿童被随机分配到每一组(股外侧n=31,腹股沟n=31)。在手术过程中,两组儿童均使用“嗡嗡”和“深呼吸”来缓解疼痛。数据通过信息表、视觉模拟量表和面部疼痛量表获得。结果:与股外侧肌组相比,腹臀肌组患儿在肌内注射时的视觉模拟评分和术后即刻面部疼痛评分较低,即疼痛较少,两组间差异有统计学意义(p)。在儿童中,建议选择疼痛较小的腹肌区域进行肌内注射,并告知卫生专业人员。
{"title":"Comparison of pain levels developed during intramuscular injections to laterofemoral and ventrogluteal regions in children: a randomized controlled study.","authors":"Serap Balci,&nbsp;Birsen Bilgen Sivri","doi":"10.1590/1806-9282.20220770","DOIUrl":"https://doi.org/10.1590/1806-9282.20220770","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to compare the levels of pain developed during intramuscular injections to the laterofemoral and ventrogluteal regions in children.</p><p><strong>Methods: </strong>The study population consisted of all children aged between 7 and 12 years who presented to the pediatric emergency clinic of a hospital. The sample consisted of 62 children who met the inclusion criteria and agreed to participate in the study, and the children were randomly assigned to each group (laterofemoral n=31, ventrogluteal n=31). \"Buzzy\" and \"deep breathing\" were applied to children in both groups to relieve pain during the procedure. The data were obtained using an Information Form, a visual analog scale, and the Facial Pain Scale-Revised.</p><p><strong>Results: </strong>It was determined that the children in the ventrogluteal group during the intramuscular injections had lower visual analog scale and faces pain scale-revised scores immediately after the procedure compared with the vastus lateralis group, that is, they experienced less pain, and the difference between the two groups was significant (p<0.001).</p><p><strong>Conclusion: </strong>In children, it is recommended to choose the less painful ventrogluteal region for intramuscular injection and to inform health professionals about it.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/bd/1806-9282-ramb-69-01-0085.PMC9937611.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9325145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of candesartan treatment on echocardiographic indices of cardiac remodeling in post-myocardial infarction patients. 坎地沙坦治疗对心肌梗死后患者心脏重构超声心动图指标的影响。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20220720
Hüseyin Tezcan, Abdullah Tunçez, Kenan Demir, Bulent Behlül Altunkeser, Nazif Aygül, Muhammed Ulvi Yalcin, Muhammed Salih Ates, Canan Aydoğan, Onur Can Polat, Aslıhan Merve Toprak

Objective: Myocardial infarction has unfavorable effect on structural and functional properties of the myocardium, referred to as cardiac remodeling. Left ventricular mass, left ventricular mass index, and relative wall thickness are important predictors of cardiac remodeling. In this study, we investigated the effect of candesartan treatment in comparison with zofenopril treatment on echocardiographic indices of cardiac remodeling in post myocardial infarction patients.

Material and methods: In this prospective study, patients who underwent successful percutaneous coronary intervention were randomly assigned to a candesartan or zofenopril treatment. After randomization, echocardiographic indices of cardiac remodeling including left ventricular mass, left ventricular mass index, and relative wall thickness were evaluated before the start of treatment along with 1- and 6-month follow-ups.

Results: According to our study, candesartan group showed significant reduction of estimated left ventricular mass and left ventricular mass index at 6-month follow-up visit compared to baseline values (199.53±38.51 g vs. 212.69±40.82 g; 99.05 g/m2 (90.00-116.5) vs. 106.0 g/m2 (96.0∼123.00), p<0.05, respectively). This trend was also observed in zofenopril group during the 6-month period (201.22±40.07 g vs. 207.52±41.61 g; 101.0 g/m2 (92.25-111.75.0) vs. 104.50 g/m2 (95.0∼116.75), p<0.05, respectively). Although both classes of drugs had favorable effects on post-myocardial infarction cardiac remodeling, the absolute benefit was more prominent in candesartan group as compared to zofenopril group (p<0.05).

Conclusion: Our results suggest that candesartan treatment following myocardial infarction may potentially be useful in terms of improving post-myocardial infarction cardiac remodeling.

目的:心肌梗死对心肌的结构和功能特性产生不利影响,即心肌重构。左室质量、左室质量指数和相对壁厚是心脏重构的重要预测指标。在本研究中,我们比较了坎地沙坦治疗与佐非普利治疗对心肌梗死后患者心脏重构超声心动图指标的影响。材料和方法:在这项前瞻性研究中,成功接受经皮冠状动脉介入治疗的患者被随机分配到坎地沙坦或佐非诺普利治疗组。随机分组后,在治疗开始前评估心脏重构的超声心动图指标,包括左心室质量、左心室质量指数和相对壁厚,并进行1个月和6个月的随访。结果:根据我们的研究,坎地沙坦组在随访6个月时左室质量和左室质量指数与基线值相比显著降低(199.53±38.51 g vs. 212.69±40.82 g;99.05 g/m2 (90.0 ~ 116.5) vs. 106.0 g/m2(96.0 ~ 123.00),结论:我们的研究结果表明,心肌梗死后坎地沙坦治疗可能对改善心肌梗死后心脏重构有潜在的作用。
{"title":"Effect of candesartan treatment on echocardiographic indices of cardiac remodeling in post-myocardial infarction patients.","authors":"Hüseyin Tezcan,&nbsp;Abdullah Tunçez,&nbsp;Kenan Demir,&nbsp;Bulent Behlül Altunkeser,&nbsp;Nazif Aygül,&nbsp;Muhammed Ulvi Yalcin,&nbsp;Muhammed Salih Ates,&nbsp;Canan Aydoğan,&nbsp;Onur Can Polat,&nbsp;Aslıhan Merve Toprak","doi":"10.1590/1806-9282.20220720","DOIUrl":"https://doi.org/10.1590/1806-9282.20220720","url":null,"abstract":"<p><strong>Objective: </strong>Myocardial infarction has unfavorable effect on structural and functional properties of the myocardium, referred to as cardiac remodeling. Left ventricular mass, left ventricular mass index, and relative wall thickness are important predictors of cardiac remodeling. In this study, we investigated the effect of candesartan treatment in comparison with zofenopril treatment on echocardiographic indices of cardiac remodeling in post myocardial infarction patients.</p><p><strong>Material and methods: </strong>In this prospective study, patients who underwent successful percutaneous coronary intervention were randomly assigned to a candesartan or zofenopril treatment. After randomization, echocardiographic indices of cardiac remodeling including left ventricular mass, left ventricular mass index, and relative wall thickness were evaluated before the start of treatment along with 1- and 6-month follow-ups.</p><p><strong>Results: </strong>According to our study, candesartan group showed significant reduction of estimated left ventricular mass and left ventricular mass index at 6-month follow-up visit compared to baseline values (199.53±38.51 g vs. 212.69±40.82 g; 99.05 g/m2 (90.00-116.5) vs. 106.0 g/m2 (96.0∼123.00), p<0.05, respectively). This trend was also observed in zofenopril group during the 6-month period (201.22±40.07 g vs. 207.52±41.61 g; 101.0 g/m2 (92.25-111.75.0) vs. 104.50 g/m2 (95.0∼116.75), p<0.05, respectively). Although both classes of drugs had favorable effects on post-myocardial infarction cardiac remodeling, the absolute benefit was more prominent in candesartan group as compared to zofenopril group (p<0.05).</p><p><strong>Conclusion: </strong>Our results suggest that candesartan treatment following myocardial infarction may potentially be useful in terms of improving post-myocardial infarction cardiac remodeling.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/69/1806-9282-ramb-69-01-0078.PMC9937609.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9325146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option. 免疫吸附治疗难治性心力衰竭合并扩张型心肌病:一种潜在的治疗选择。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20220784
Yuksel Cavusoglu, Senan Tahmazov, Selda Murat, Olga Meltem Akay
SUMMARY OBJECTIVE: Removal of cardiac autoantibodies by immunoadsorption might confer clinical improvement in dilated cardiomyopathy. In this pilot study, we investigated the efficacy and safety of immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy. METHODS: This study consisted of 9 heart failure patients with dilated cardiomyopathy, NYHA III-IV, left ventricular ejection fraction <30%, unresponsive to heart failure therapy, and with cardiac autoantibodies. Patients underwent immunoadsorption therapy for five consecutive days using a tryptophan column. Changes in cardiac function (left ventricular ejection fraction, left ventricular end-diastolic diameter, left ventricular end-systolic diameter), exercise capacity (6-minute walk distance), neurohormonal (N-terminal pro-brain natriuretic peptide), proinflammatory (high-sensitive C-reactive protein), and myocardial (cardiac troponin-I), biochemical, and hematological variables were obtained at baseline and after 3 and 6 months of immunoadsorption therapy. RESULTS: Mean left ventricular ejection fraction and 6-minute walk distance significantly increased at 3 months (from 23.27±5.09 to 32.1±1.7%, p=0.01 for left ventricular ejection fraction and from 353±118 to 434±159 m, p=0.04 for 6-minute walk distance) and further increased at 6 months after immunoadsorption therapy (to 34.5±7.7%, p=0.02 for ejection fraction and to 441±136 m, p=0.04 for 6-minute walk distance). NT-proBNP level reduced from 1161(392.8–3034) to 385(116.1–656.5) ng/L (p=0.04), and high-sensitive C-reactive protein decreased from 9.74±0.96 to 4.3±5.8 mg/L (p=0.04) at 6 months. Left ventricular end-diastolic diameter (66.1±5.8 vs. 64.7±8.9 mm) and left ventricular end-systolic diameter (56.1±8.6 vs. 52.3±10.8 mm) tended to decrease but did not reach statistical significance. No significant worsening was observed in creatinine, cardiac troponin-I, and hemoglobin levels after the immunoadsorption procedure. CONCLUSION: In dilated cardiomyopathy patients with refractory heart failure, immunoadsorption may be considered a potentially useful therapeutic option to improve a patient's clinical status.
目的:免疫吸附法去除心脏自身抗体可能改善扩张型心肌病的临床疗效。在这项初步研究中,我们研究了免疫吸附治疗难治性心力衰竭合并扩张型心肌病患者的疗效和安全性。方法:9例心衰合并扩张型心肌病患者,NYHA III-IV,左心室射血分数。平均左室射血分数和6分钟步行距离在3个月时显著增加(左室射血分数从23.27±5.09增加到32.1±1.7%,p=0.01, 6分钟步行距离从353±118增加到434±159 m, p=0.04),并在免疫吸附治疗后6个月进一步增加(射血分数为34.5±7.7%,p=0.02, 6分钟步行距离为441±136 m, p=0.04)。6个月时NT-proBNP水平从1161(392.8-3034)降至385(116.1-656.5)ng/L (p=0.04),高敏c反应蛋白从9.74±0.96降至4.3±5.8 mg/L (p=0.04)。左室舒张末期内径(66.1±5.8比64.7±8.9 mm)和左室收缩末期内径(56.1±8.6比52.3±10.8 mm)有减小的趋势,但无统计学意义。免疫吸附手术后肌酐、心肌肌钙蛋白- 1和血红蛋白水平未见明显恶化。结论:在扩张型心肌病合并难治性心衰患者中,免疫吸附可能被认为是一种潜在有用的治疗选择,可以改善患者的临床状况。
{"title":"Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option.","authors":"Yuksel Cavusoglu,&nbsp;Senan Tahmazov,&nbsp;Selda Murat,&nbsp;Olga Meltem Akay","doi":"10.1590/1806-9282.20220784","DOIUrl":"https://doi.org/10.1590/1806-9282.20220784","url":null,"abstract":"SUMMARY OBJECTIVE: Removal of cardiac autoantibodies by immunoadsorption might confer clinical improvement in dilated cardiomyopathy. In this pilot study, we investigated the efficacy and safety of immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy. METHODS: This study consisted of 9 heart failure patients with dilated cardiomyopathy, NYHA III-IV, left ventricular ejection fraction <30%, unresponsive to heart failure therapy, and with cardiac autoantibodies. Patients underwent immunoadsorption therapy for five consecutive days using a tryptophan column. Changes in cardiac function (left ventricular ejection fraction, left ventricular end-diastolic diameter, left ventricular end-systolic diameter), exercise capacity (6-minute walk distance), neurohormonal (N-terminal pro-brain natriuretic peptide), proinflammatory (high-sensitive C-reactive protein), and myocardial (cardiac troponin-I), biochemical, and hematological variables were obtained at baseline and after 3 and 6 months of immunoadsorption therapy. RESULTS: Mean left ventricular ejection fraction and 6-minute walk distance significantly increased at 3 months (from 23.27±5.09 to 32.1±1.7%, p=0.01 for left ventricular ejection fraction and from 353±118 to 434±159 m, p=0.04 for 6-minute walk distance) and further increased at 6 months after immunoadsorption therapy (to 34.5±7.7%, p=0.02 for ejection fraction and to 441±136 m, p=0.04 for 6-minute walk distance). NT-proBNP level reduced from 1161(392.8–3034) to 385(116.1–656.5) ng/L (p=0.04), and high-sensitive C-reactive protein decreased from 9.74±0.96 to 4.3±5.8 mg/L (p=0.04) at 6 months. Left ventricular end-diastolic diameter (66.1±5.8 vs. 64.7±8.9 mm) and left ventricular end-systolic diameter (56.1±8.6 vs. 52.3±10.8 mm) tended to decrease but did not reach statistical significance. No significant worsening was observed in creatinine, cardiac troponin-I, and hemoglobin levels after the immunoadsorption procedure. CONCLUSION: In dilated cardiomyopathy patients with refractory heart failure, immunoadsorption may be considered a potentially useful therapeutic option to improve a patient's clinical status.","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/ec/1806-9282-ramb-69-01-0090.PMC9937600.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9325148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of patients of vaccine side effects after the COVID-19 vaccine. COVID-19疫苗接种后疫苗副作用患者评价。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20221035
Muhammed Semih Gedik, Ali İhsan Kilci, Hakan Hakkoymaz, Ömer Faruk Küçük, Yavuzalp Solak, Nuri Mehmet Basan, Yunus Emre Çıkrıkçı

Objective: Postvaccine side effects were evaluated in patients presenting to our emergency department with complaints of vaccine side effects after taking COVID-19 vaccine, and new unknown side effects ranging from mild complaints to life-threatening risks, and frequency of all side effects were investigated. This study aimed to establish a scientific resource to identify the potential side effects of the vaccine.

Methods: Patients' demographic information, clinical characteristics, epicrisis reports, COVID-19 disease and vaccination histories, vital values, and blood values were examined. The SPSS 20.0 package program was used for statistical evaluation. p<0.05 was considered statistically significant.

Results: Notably, 13.1% of patients presenting to the emergency department started to have complaints after taking Sinovac vaccine, whereas 86.9% of them had complaints after taking BioNTech vaccine. Also, 36.9% of patients stated that they had COVID-19. All patients had a Glasgow coma scale score of 15 during admission. No patient was hospitalized, ventilator was not needed, and all patients were discharged. While the most common presenting complaint to the emergency department after vaccination was fatigue in 29.7%, the most common diagnoses after examination in the emergency department were myalgia in 32.1% and upper respiratory tract infection in 28.6%.

Conclusion: Results and conclusions of our study will guide healthcare workers and patients on the side effects of COVID-19 vaccine.

目的:评估以新冠肺炎疫苗副反应为主诉就诊于急诊科的患者接种后疫苗副反应情况,以及新出现的未知副反应,从轻微主诉到危及生命的危险,并调查所有副反应发生的频率。本研究旨在建立科学资源,以确定疫苗的潜在副作用。方法:对患者的人口学资料、临床特征、疫情报告、COVID-19疾病及疫苗接种史、生命体征、血值进行统计。采用SPSS 20.0软件包程序进行统计评价。结果:值得注意的是,到急诊科就诊的患者中,有13.1%的人在接种了科兴疫苗后开始有投诉,而86.9%的人在接种了BioNTech疫苗后开始有投诉。36.9%的患者表示自己感染了新冠病毒。所有患者入院时格拉斯哥昏迷评分为15分。无患者住院,无需呼吸机,全部出院。接种疫苗后到急诊科最常见的主诉是疲劳(29.7%),急诊科检查后最常见的诊断是肌痛(32.1%)和上呼吸道感染(28.6%)。结论:我们的研究结果和结论将指导医护人员和患者了解COVID-19疫苗的副作用。
{"title":"Evaluation of patients of vaccine side effects after the COVID-19 vaccine.","authors":"Muhammed Semih Gedik,&nbsp;Ali İhsan Kilci,&nbsp;Hakan Hakkoymaz,&nbsp;Ömer Faruk Küçük,&nbsp;Yavuzalp Solak,&nbsp;Nuri Mehmet Basan,&nbsp;Yunus Emre Çıkrıkçı","doi":"10.1590/1806-9282.20221035","DOIUrl":"https://doi.org/10.1590/1806-9282.20221035","url":null,"abstract":"<p><strong>Objective: </strong>Postvaccine side effects were evaluated in patients presenting to our emergency department with complaints of vaccine side effects after taking COVID-19 vaccine, and new unknown side effects ranging from mild complaints to life-threatening risks, and frequency of all side effects were investigated. This study aimed to establish a scientific resource to identify the potential side effects of the vaccine.</p><p><strong>Methods: </strong>Patients' demographic information, clinical characteristics, epicrisis reports, COVID-19 disease and vaccination histories, vital values, and blood values were examined. The SPSS 20.0 package program was used for statistical evaluation. p<0.05 was considered statistically significant.</p><p><strong>Results: </strong>Notably, 13.1% of patients presenting to the emergency department started to have complaints after taking Sinovac vaccine, whereas 86.9% of them had complaints after taking BioNTech vaccine. Also, 36.9% of patients stated that they had COVID-19. All patients had a Glasgow coma scale score of 15 during admission. No patient was hospitalized, ventilator was not needed, and all patients were discharged. While the most common presenting complaint to the emergency department after vaccination was fatigue in 29.7%, the most common diagnoses after examination in the emergency department were myalgia in 32.1% and upper respiratory tract infection in 28.6%.</p><p><strong>Conclusion: </strong>Results and conclusions of our study will guide healthcare workers and patients on the side effects of COVID-19 vaccine.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/b6/1806-9282-ramb-69-01-0147.PMC9937590.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9326597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Relationship between platelet indices and red cell distribution width and short-term mortality in traumatic brain injury with 30-day mortality. 外伤性脑损伤血小板指数、红细胞分布宽度与短期死亡率及30天死亡率的关系
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.00210889
Onur Palabiyik, Yakup Tomak, Muberra Acar, Unal Erkorkmaz, Ayca Tas Tuna, Kezban Ozmen Suner, Davut Ceylan

Objective: This study aimed at investigating whether there is a relationship between 7- or 30-day mortality and mean platelet volume, platelet distribution width, platelet count-to-total lymphocyte count ratio, or red cell distribution width in patients with traumatic brain injury.

Methods: We retrospectively analyzed intensive care unit patients with traumatic brain injury. We recorded patients' ages; genders; diagnoses; Glasgow Coma Scale scores; length of intensive care unit stay (in days); mean platelet volume, platelet distribution width, platelet count-to-total lymphocyte count ratio, and red cell distribution width values upon hospital admission; and health on the 7th and 30th days of their stays.

Results: We analyzed data from 110 patients. Of these, 84 (76.4%) were male and 26 (23.6%) were female. On the 7- and 30-day mortality evaluations, compared to the living patients, the deceased patients had a significantly higher median age and a significantly lower median Glasgow Coma Scale. Thus, increased age and lower Glasgow Coma Scale scores were associated with increased 7- and 30-day mortality rates. mean platelet volume and platelet distribution width values were similar in living and deceased patients. platelet count-to-total lymphocyte count ratio values were lower in deceased patients, but this difference was not statistically significant. Within 30 days after traumatic brain injury, deceased patients' red cell distribution width values were significantly elevated in deceased patients compared to those of living patients.

Conclusion: Mean platelet volume, platelet distribution width, and platelet count-to-total lymphocyte count ratio values were not associated with 7- and 30-day mortality, whereas only elevated red cell distribution width was associated with 30-day mortality.

目的:本研究旨在探讨创伤性脑损伤患者7天或30天死亡率与平均血小板体积、血小板分布宽度、血小板计数与总淋巴细胞计数比、红细胞分布宽度之间的关系。方法:回顾性分析重症监护病房外伤性脑损伤患者。我们记录了患者的年龄;性别;诊断;格拉斯哥昏迷量表评分;重症监护病房住院时间(以天为单位);入院时平均血小板体积、血小板分布宽度、血小板计数与总淋巴细胞计数比、红细胞分布宽度值;在他们停留的第7天和第30天进行健康检查。结果:我们分析了110例患者的数据。其中男性84例(76.4%),女性26例(23.6%)。在7天和30天的死亡率评估中,与活着的患者相比,死亡患者的中位年龄明显较高,中位格拉斯哥昏迷评分明显较低。因此,年龄的增加和格拉斯哥昏迷评分的降低与7天和30天死亡率的增加有关。在世和死亡患者的平均血小板体积和血小板分布宽度值相似。死亡患者血小板计数与总淋巴细胞计数比值值较低,但差异无统计学意义。创伤性脑损伤后30天内,死亡患者红细胞分布宽度值明显高于活着的患者。结论:平均血小板体积、血小板分布宽度和血小板计数与总淋巴细胞计数比值值与7天和30天死亡率无关,而只有红细胞分布宽度升高与30天死亡率相关。
{"title":"Relationship between platelet indices and red cell distribution width and short-term mortality in traumatic brain injury with 30-day mortality.","authors":"Onur Palabiyik,&nbsp;Yakup Tomak,&nbsp;Muberra Acar,&nbsp;Unal Erkorkmaz,&nbsp;Ayca Tas Tuna,&nbsp;Kezban Ozmen Suner,&nbsp;Davut Ceylan","doi":"10.1590/1806-9282.00210889","DOIUrl":"https://doi.org/10.1590/1806-9282.00210889","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed at investigating whether there is a relationship between 7- or 30-day mortality and mean platelet volume, platelet distribution width, platelet count-to-total lymphocyte count ratio, or red cell distribution width in patients with traumatic brain injury.</p><p><strong>Methods: </strong>We retrospectively analyzed intensive care unit patients with traumatic brain injury. We recorded patients' ages; genders; diagnoses; Glasgow Coma Scale scores; length of intensive care unit stay (in days); mean platelet volume, platelet distribution width, platelet count-to-total lymphocyte count ratio, and red cell distribution width values upon hospital admission; and health on the 7th and 30th days of their stays.</p><p><strong>Results: </strong>We analyzed data from 110 patients. Of these, 84 (76.4%) were male and 26 (23.6%) were female. On the 7- and 30-day mortality evaluations, compared to the living patients, the deceased patients had a significantly higher median age and a significantly lower median Glasgow Coma Scale. Thus, increased age and lower Glasgow Coma Scale scores were associated with increased 7- and 30-day mortality rates. mean platelet volume and platelet distribution width values were similar in living and deceased patients. platelet count-to-total lymphocyte count ratio values were lower in deceased patients, but this difference was not statistically significant. Within 30 days after traumatic brain injury, deceased patients' red cell distribution width values were significantly elevated in deceased patients compared to those of living patients.</p><p><strong>Conclusion: </strong>Mean platelet volume, platelet distribution width, and platelet count-to-total lymphocyte count ratio values were not associated with 7- and 30-day mortality, whereas only elevated red cell distribution width was associated with 30-day mortality.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/83/1806-9282-ramb-69-01-0018.PMC9937619.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9341421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of dexmedetomidine on tourniquet-induced skeletal muscle injury. 右美托咪定对止血带所致骨骼肌损伤的影响。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20220865
Wenjie Cheng, Zhe Wu, Jizheng Zhang, Wanlu Ren

Objective: The aim of this study was to investigate whether dexmedetomidine could reduce tourniquet-induced skeletal muscle injury.

Methods: C57BL6 male mice were randomly assigned to sham, ischemia/reperfusion, and dexmedetomidine groups. Mice in the ischemia/reperfusion and dexmedetomidine groups received normal saline solution and dexmedetomidine intraperitoneally, respectively. The sham group underwent the same procedure as the ischemia/reperfusion group, with the exception of tourniquet application. Subsequently, the ultrastructure of the gastrocnemius muscle was observed, and its contractile force was examined. In addition, Toll-like receptor 4 and nuclear factor-κB expression within muscles was detected by Western blot.

Results: Dexmedetomidine alleviated myocyte damage and increased the contractility of skeletal muscles. Moreover, dexmedetomidine significantly inhibited the expression of Toll-like receptor 4/nuclear factor-κB in the gastrocnemius muscle.

Conclusion: Taken together, these results demonstrate that dexmedetomidine administration attenuated tourniquet-induced structural and functional impairment of the skeletal muscle, partly through inactivation of the Toll-like receptor 4/nuclear factor-κB pathway.

目的:探讨右美托咪定是否能减轻止血带所致骨骼肌损伤。方法:C57BL6雄性小鼠随机分为假手术组、缺血再灌注组和右美托咪定组。缺血再灌注组和右美托咪定组小鼠分别腹腔注射生理盐水和右美托咪定。假手术组除止血带外,手术过程与缺血再灌注组相同。观察腓肠肌的超微结构,测定腓肠肌的收缩力。Western blot检测toll样受体4和核因子-κB在肌肉中的表达。结果:右美托咪定减轻了骨骼肌细胞的损伤,增加了骨骼肌的收缩力。右美托咪定显著抑制腓肠肌toll样受体4/核因子-κB的表达。结论:综上所述,这些结果表明右美托咪定减轻了止血带引起的骨骼肌结构和功能损伤,部分原因是toll样受体4/核因子-κB通路失活。
{"title":"Effect of dexmedetomidine on tourniquet-induced skeletal muscle injury.","authors":"Wenjie Cheng,&nbsp;Zhe Wu,&nbsp;Jizheng Zhang,&nbsp;Wanlu Ren","doi":"10.1590/1806-9282.20220865","DOIUrl":"https://doi.org/10.1590/1806-9282.20220865","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate whether dexmedetomidine could reduce tourniquet-induced skeletal muscle injury.</p><p><strong>Methods: </strong>C57BL6 male mice were randomly assigned to sham, ischemia/reperfusion, and dexmedetomidine groups. Mice in the ischemia/reperfusion and dexmedetomidine groups received normal saline solution and dexmedetomidine intraperitoneally, respectively. The sham group underwent the same procedure as the ischemia/reperfusion group, with the exception of tourniquet application. Subsequently, the ultrastructure of the gastrocnemius muscle was observed, and its contractile force was examined. In addition, Toll-like receptor 4 and nuclear factor-κB expression within muscles was detected by Western blot.</p><p><strong>Results: </strong>Dexmedetomidine alleviated myocyte damage and increased the contractility of skeletal muscles. Moreover, dexmedetomidine significantly inhibited the expression of Toll-like receptor 4/nuclear factor-κB in the gastrocnemius muscle.</p><p><strong>Conclusion: </strong>Taken together, these results demonstrate that dexmedetomidine administration attenuated tourniquet-induced structural and functional impairment of the skeletal muscle, partly through inactivation of the Toll-like receptor 4/nuclear factor-κB pathway.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/70/c7/1806-9282-ramb-69-02-0228.PMC9983473.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9434173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comments on "Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial". “冷却剂喷雾对老年钝性胸外伤患者肋骨骨折疼痛的影响:一项随机对照试验”。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20230091
André Pontes-Silva, Karolayne Dos Santos Lima, Cassius Iury Anselmo-E-Silva, André Luiz Lopes, Aldair Darlan Santos-de-Araújo
This paper 1 aimed to evaluate the effectiveness of cryotherapy in elderly patients with rib fractures due to blunt thoracic trauma via a prospective randomized controlled study (coolant spray group, n=51; placebo spray group, n=50). The authors concluded that coolant spray therapy can be used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients; however, some points of this research do not support this conclusion. First of all, the authors did not describe the study hypothesis (this weakens the results). Second, they did not present the minimal clinically important change of the VAS on the patients’ pain level (making it impossible to analyze clinical relevance). Comparisons of outcomes in clinical trials should consider the minimal clinically important change of the mean differences because the p-value only shows statistical significance, which interpretation translates just a hypothesis test governed by a probability of previously defined error ( α ) 2,3 . Third, they did not present the assess the effect size (e.g., Cohen’s d=[M1–M2]/S pooled ) 4,5 of the comparisons between the times and groups (making it impossible [again] to analyze clinical relevance). Fourth, they should have assessed the patients’ disability for pre-and post-intervention comparisons. As such, the new conclusion is as follows: although this study has shown significant differences between coolant spray therapy and placebo (used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients), its clinical relevance is yet unknown.
{"title":"Comments on \"Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial\".","authors":"André Pontes-Silva,&nbsp;Karolayne Dos Santos Lima,&nbsp;Cassius Iury Anselmo-E-Silva,&nbsp;André Luiz Lopes,&nbsp;Aldair Darlan Santos-de-Araújo","doi":"10.1590/1806-9282.20230091","DOIUrl":"https://doi.org/10.1590/1806-9282.20230091","url":null,"abstract":"This paper 1 aimed to evaluate the effectiveness of cryotherapy in elderly patients with rib fractures due to blunt thoracic trauma via a prospective randomized controlled study (coolant spray group, n=51; placebo spray group, n=50). The authors concluded that coolant spray therapy can be used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients; however, some points of this research do not support this conclusion. First of all, the authors did not describe the study hypothesis (this weakens the results). Second, they did not present the minimal clinically important change of the VAS on the patients’ pain level (making it impossible to analyze clinical relevance). Comparisons of outcomes in clinical trials should consider the minimal clinically important change of the mean differences because the p-value only shows statistical significance, which interpretation translates just a hypothesis test governed by a probability of previously defined error ( α ) 2,3 . Third, they did not present the assess the effect size (e.g., Cohen’s d=[M1–M2]/S pooled ) 4,5 of the comparisons between the times and groups (making it impossible [again] to analyze clinical relevance). Fourth, they should have assessed the patients’ disability for pre-and post-intervention comparisons. As such, the new conclusion is as follows: although this study has shown significant differences between coolant spray therapy and placebo (used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients), its clinical relevance is yet unknown.","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/00/19/1806-9282-ramb-69-05-e20230091.PMC10204835.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9878863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial. 冷却剂喷雾对老年钝性胸外伤患者肋骨骨折疼痛的影响:一项随机对照试验。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20220048
İlker Akbaş, Sinem Dogruyol, Abdullah Osman Kocak, Talha Dogruyol, Meryem Betos Koçak, Sultan Tuna Akgol Gur, Zeynep Cakir

Objective: This study aimed to evaluate the effectiveness of cryotherapy in elderly patients with rib fractures due to blunt thoracic trauma.

Methods: In this prospective randomized controlled study, geriatric patients were assigned to groups to receive either coolant spray (n=51) or placebo spray (n=50). The visual analog scale scores of all patients were recorded before starting spray application (V0), as well as at 10th (V1), 20th (V2), 30th (V3), 60th (V4), 120th (V5), and 360th (V6) minute. The mean decreases in the visual analog scale scores were calculated.

Results: The differences between V0 and V1, V0 and V2, V0 and V3, and V0 and V4 mean visual analog scale scores measured in the coolant spray group were found to be significantly higher (p<0.001). In V1, V2, V3, and V4 measurements, the incidence of "clinical effectiveness" in the coolant spray group was significantly higher than in the placebo group (p=0.001).

Conclusions: Coolant spray therapy can be used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients.

目的:探讨冷冻治疗老年钝性胸外伤所致肋骨骨折的疗效。方法:在这项前瞻性随机对照研究中,老年患者被分配到接受冷却剂喷雾(n=51)或安慰剂喷雾(n=50)的组。记录所有患者在开始喷雾前(V0)、第10分钟(V1)、第20分钟(V2)、第30分钟(V3)、第60分钟(V4)、第120分钟(V5)、第360分钟(V6)时的视觉模拟量表评分。计算视觉模拟量表得分的平均下降。结果:冷却剂喷雾组的V0与V1、V0与V2、V0与V3、V0与V4的平均视觉模拟量表评分差异显著较高(p)。结论:冷却剂喷雾治疗可作为多模式治疗的一个组成部分,为老年肋骨骨折患者提供充分的镇痛。
{"title":"Effect of coolant spray on rib fracture pain of geriatric blunt thoracic trauma patients: a randomized controlled trial.","authors":"İlker Akbaş,&nbsp;Sinem Dogruyol,&nbsp;Abdullah Osman Kocak,&nbsp;Talha Dogruyol,&nbsp;Meryem Betos Koçak,&nbsp;Sultan Tuna Akgol Gur,&nbsp;Zeynep Cakir","doi":"10.1590/1806-9282.20220048","DOIUrl":"https://doi.org/10.1590/1806-9282.20220048","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of cryotherapy in elderly patients with rib fractures due to blunt thoracic trauma.</p><p><strong>Methods: </strong>In this prospective randomized controlled study, geriatric patients were assigned to groups to receive either coolant spray (n=51) or placebo spray (n=50). The visual analog scale scores of all patients were recorded before starting spray application (V0), as well as at 10th (V1), 20th (V2), 30th (V3), 60th (V4), 120th (V5), and 360th (V6) minute. The mean decreases in the visual analog scale scores were calculated.</p><p><strong>Results: </strong>The differences between V0 and V1, V0 and V2, V0 and V3, and V0 and V4 mean visual analog scale scores measured in the coolant spray group were found to be significantly higher (p<0.001). In V1, V2, V3, and V4 measurements, the incidence of \"clinical effectiveness\" in the coolant spray group was significantly higher than in the placebo group (p=0.001).</p><p><strong>Conclusions: </strong>Coolant spray therapy can be used as a component of multimodal therapy to provide adequate analgesia due to rib fractures in geriatric patients.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7f/38/1806-9282-ramb-69-01-0030.PMC9937612.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9890673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Impact of breast augmentation on female sexuality. 隆胸对女性性欲的影响。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.2023S105
Paulo Afonso Monteiro Pacheco Guimarães, Elisa Mayumi Kokuba Aihara, Miguel Sabino Neto, Mateus Leme De Marchi, Lydia Masako Ferreira

Introduction: The breasts are symbols of femininity, sexuality, and maternity. Breast augmentation is among the most sought-after procedures for women and has a positive impact on quality of life. Sexuality is one of the items that contribute to increased quality of life. Surgical outcomes can be evaluated from the patients' perspective using developed and validated questionnaires. For the assessment of sexuality, the most commonly used instruments are the Female Sexual Quotient and the Female Sexual Function Index, which estimate several domains of sexuality and can be used to evaluate the impact of surgery on it.

Objective: The objective of this study was to evaluate the impact of breast augmentation on female sexuality.

Methods: We selected 87 patients from the Plastic Surgery Outpatient Clinic of Hospital São Paulo (Federal University of São Paulo) who wished to undergo breast augmentation. The patients were classified into two groups: the Female Sexual Quotient questionnaire was applied to one group, and the Female Sexual Function Index questionnaire was applied to the other group to evaluate sexuality preoperatively as well as at 2 and 4 months postoperatively.

Results: In both groups, there was a significant increase in the total score of the Female Sexual Quotient and Female Sexual Function Index questionnaires, and an individual increase in each domain assessed, with a significant increase in the domains of orgasm and sexual satisfaction, as well as foreplay and arousal, indicating an improvement in the patients' sexuality postoperatively.

Conclusion: Breast augmentation has a positive impact on female sexuality; furthermore, the Female Sexual Quotient and Female Sexual Function Index are sensitive in detecting this impact.

简介:乳房是女性气质、性欲和母性的象征。隆胸是最受女性欢迎的手术之一,对生活质量有积极的影响。性是提高生活质量的因素之一。手术结果可以从患者的角度评估使用开发和验证问卷。对于性行为的评估,最常用的工具是女性性商和女性性功能指数,它们可以评估性行为的几个领域,并可用于评估手术对其的影响。目的:本研究的目的是评估隆胸对女性性行为的影响。方法:选取圣保罗联邦大学整形外科门诊87例拟行隆胸手术的患者。将患者分为两组,一组采用女性性商问卷,另一组采用女性性功能指数问卷,分别于术前及术后2、4个月对患者的性行为进行评价。结果:两组患者的“女性性商”和“女性性功能指数”问卷总分均有显著提高,且各评估领域均有个体提高,其中性高潮和性满足、前戏和性唤起等领域均有显著提高,表明患者术后性行为有所改善。结论:隆胸对女性性欲有积极影响;此外,女性性商和女性性功能指数对这种影响的检测较为敏感。
{"title":"Impact of breast augmentation on female sexuality.","authors":"Paulo Afonso Monteiro Pacheco Guimarães,&nbsp;Elisa Mayumi Kokuba Aihara,&nbsp;Miguel Sabino Neto,&nbsp;Mateus Leme De Marchi,&nbsp;Lydia Masako Ferreira","doi":"10.1590/1806-9282.2023S105","DOIUrl":"https://doi.org/10.1590/1806-9282.2023S105","url":null,"abstract":"<p><strong>Introduction: </strong>The breasts are symbols of femininity, sexuality, and maternity. Breast augmentation is among the most sought-after procedures for women and has a positive impact on quality of life. Sexuality is one of the items that contribute to increased quality of life. Surgical outcomes can be evaluated from the patients' perspective using developed and validated questionnaires. For the assessment of sexuality, the most commonly used instruments are the Female Sexual Quotient and the Female Sexual Function Index, which estimate several domains of sexuality and can be used to evaluate the impact of surgery on it.</p><p><strong>Objective: </strong>The objective of this study was to evaluate the impact of breast augmentation on female sexuality.</p><p><strong>Methods: </strong>We selected 87 patients from the Plastic Surgery Outpatient Clinic of Hospital São Paulo (Federal University of São Paulo) who wished to undergo breast augmentation. The patients were classified into two groups: the Female Sexual Quotient questionnaire was applied to one group, and the Female Sexual Function Index questionnaire was applied to the other group to evaluate sexuality preoperatively as well as at 2 and 4 months postoperatively.</p><p><strong>Results: </strong>In both groups, there was a significant increase in the total score of the Female Sexual Quotient and Female Sexual Function Index questionnaires, and an individual increase in each domain assessed, with a significant increase in the domains of orgasm and sexual satisfaction, as well as foreplay and arousal, indicating an improvement in the patients' sexuality postoperatively.</p><p><strong>Conclusion: </strong>Breast augmentation has a positive impact on female sexuality; furthermore, the Female Sexual Quotient and Female Sexual Function Index are sensitive in detecting this impact.</p>","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/9e/1806-9282-ramb-69-suppl1-e2023S105.PMC10411706.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9975674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Prognostic value of T-wave positivity in lead aVR in COVID-19 pneumonia". 关于“t波阳性导联aVR在COVID-19肺炎中的预后价值”的评论。
IF 1.4 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.1590/1806-9282.20230192
Weihua Chen
The study 1 entitled “Prognostic value of T-wave positivity in lead aVR in COVID-19 pneumonia” investigated the relationship between T-wave positivity in lead aVR and the prognosis of patients with COVID-19 pneumonia. The findings suggest that T-wave positivity in lead aVR is a useful predictor of poor prognosis in COVID-19 patients. While the findings of this study are interesting, I would like to point out some potential limitations.
{"title":"Comment on \"Prognostic value of T-wave positivity in lead aVR in COVID-19 pneumonia\".","authors":"Weihua Chen","doi":"10.1590/1806-9282.20230192","DOIUrl":"https://doi.org/10.1590/1806-9282.20230192","url":null,"abstract":"The study 1 entitled “Prognostic value of T-wave positivity in lead aVR in COVID-19 pneumonia” investigated the relationship between T-wave positivity in lead aVR and the prognosis of patients with COVID-19 pneumonia. The findings suggest that T-wave positivity in lead aVR is a useful predictor of poor prognosis in COVID-19 patients. While the findings of this study are interesting, I would like to point out some potential limitations.","PeriodicalId":21234,"journal":{"name":"Revista da Associacao Medica Brasileira","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/f4/1806-9282-ramb-69-06-e20230192.PMC10241080.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9998624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista da Associacao Medica Brasileira
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1